|
EIF4E3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.489000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.559900E-02 |
| Normal-vs-Stage2 |
5.154400E-01 |
| Normal-vs-Stage3 |
3.828000E-01 |
| Normal-vs-Stage4 |
1.933910E-02 |
| Stage1-vs-Stage2 |
6.563600E-01 |
| Stage1-vs-Stage3 |
5.757500E-03 |
| Stage1-vs-Stage4 |
2.26369999999365E-05 |
| Stage2-vs-Stage3 |
2.617400E-01 |
| Stage2-vs-Stage4 |
5.095500E-02 |
| Stage3-vs-Stage4 |
2.106200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.696200E-01 |
| Normal-vs-AfricanAmerican |
1.068010E-01 |
| Normal-vs-Asian |
3.712400E-01 |
| Caucasian-vs-AfricanAmerican |
3.646000E-02 |
| Caucasian-vs-Asian |
4.096200E-01 |
| AfricanAmerican-vs-Asian |
9.511500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.852000E-01 |
| Normal-vs-Female |
3.134300E-02 |
| Male-vs-Female |
3.641100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.297200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.530800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.714800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.806400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.423000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.646400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.585400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.035200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.290000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.862300E-03 |
| Normal-vs-Grade 2 |
3.218600E-03 |
| Normal-vs-Grade 3 |
6.460400E-01 |
| Normal-vs-Grade 4 |
2.32779999997934E-06 |
| Grade 1-vs-Grade 2 |
3.118000E-01 |
| Grade 1-vs-Grade 3 |
2.597700E-02 |
| Grade 1-vs-Grade 4 |
1.69080000000932E-06 |
| Grade 2-vs-Grade 3 |
5.407000E-04 |
| Grade 2-vs-Grade 4 |
3.68305386189149E-12 |
| Grade 3-vs-Grade 4 |
1.61850999998991E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.91429999980053E-07 |
| Normal-vs-ccB subtype |
1.211190E-01 |
| ccA subtype-vs-ccB subtype |
1.93299998230145E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.589000E-01 |
| Normal-vs-N1 |
3.376800E-01 |
| N0-vs-N1 |
1.659770E-01 |
|
|
